Your browser doesn't support javascript.
loading
FARGO-360: a multi-disciplinary survey of practice and perspectives on provision of care for patients with frailty presenting with gynecological cancers in the UK and Ireland.
Wan, Yee-Loi Louise; Cass, Gemma; Collins, Anna; Adishesh, Meera; Addley, Susan; Baker-Rand, Holly; Bharathan, Rasiah; Blake, Dominic; Beirne, James; Canavan, Lisa; Dilley, James; Fitzgibbon, Gary; Glennon, Kate; Ilenkovan, Narthana; Jones, Eleanor; Khan, Tabassum; Madhuri, Thumuluru Kavitha; McQueen, Victoria; Montgomery, Alison; O'Donnell, Rachel Louise; Watmore, Sven; White, Philip; Owens, Gemma Louise.
Afiliación
  • Wan YL; Gynaecological Oncology, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK louise.wan@manchester.ac.uk.
  • Cass G; University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Collins A; Leicester Cancer Research Centre, Leicester, UK.
  • Adishesh M; Gynaecological Oncology, Royal Preston Hospital, Preston, UK.
  • Addley S; Gynaecological Oncology, Royal Derby Hospital, Derby, UK.
  • Baker-Rand H; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Bharathan R; University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Blake D; Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead Health NHS Foundation Trust, Gateshead, UK.
  • Beirne J; Trinity Saint James Cancer Institute, Dublin, Ireland.
  • Canavan L; Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK.
  • Dilley J; Gynaecological Oncology, Barts Health NHS Trust, London, UK.
  • Fitzgibbon G; Southampton University Hospitals NHS Trust, Southampton, UK.
  • Glennon K; Mater Misericordiae University Hospital, Dublin, Ireland.
  • Ilenkovan N; Royal Hallamshire Hospital, Sheffield, UK.
  • Jones E; Gynaecological Oncology, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK.
  • Khan T; Gynaecological Oncology, University of Birmingham, Birmingham, UK.
  • Madhuri TK; Gynaecological Oncology, Royal Surrey NHS Foundation Trust, Guildford, UK.
  • McQueen V; School of Pharmacy, University of Brighton Faculty of Health and Social Sciences, Brighton, UK.
  • Montgomery A; Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK.
  • O'Donnell RL; Gynaecology, East Surrey Hospital, Redhill, UK.
  • Watmore S; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • White P; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Owens GL; University Hospital of Wales Healthcare NHS Trust, Cardiff, UK.
Int J Gynecol Cancer ; 32(7): 924-930, 2022 07 04.
Article en En | MEDLINE | ID: mdl-35534018
ABSTRACT

OBJECTIVES:

Frailty has been associated with worse cancer-related outcomes for people with gynecological cancers. However, the lack of clear guidance on how to assess and modify frailty prior to instigating active treatments has the potential to lead to large variations in practice and outcomes. This study aimed to evaluate current practice and perspectives of healthcare practitioners on the provision of care for patients with frailty and a gynecological cancer.

METHODS:

Data were collected via a questionnaire-based survey distributed by the Audit and Research in Gynecological Oncology (ARGO) collaborative to healthcare professionals who identified as working with patients with gynecological malignancies in the United Kingdom (UK) or Ireland. Study data were collected using REDCap software hosted at the University of Manchester. Responses were collected over a 16 week period between January and April 2021.

RESULTS:

A total of 206 healthcare professionals (30 anesthetists (14.6%), 30 pre-operative nurses (14.6%), 51 surgeons (24.8%), 34 cancer specialist nurses (16.5%), 21 medical/clinical oncologists (10.2%), 25 physiotherapists/occupational therapists (12.1%) and 15 dieticians (7.3%)) completed the survey. The respondents worked at 19 hospital trusts across the UK and Ireland. Frailty scoring was not routinely performed in 63% of care settings, yet the majority of practitioners reported modifying their practice when providing and deciding on care for patients with frailty. Only 16% of organizations surveyed had a dedicated pathway for assessment and management of patients with frailty. A total of 37% of respondents reported access to prehabilitation services, 79% to enhanced recovery, and 27% to community rehabilitation teams.

CONCLUSION:

Practitioners from all groups surveyed considered that appropriate training, dedicated pathways for optimization, frailty specific performance indicators and evidence that frailty scoring had an impact on clinical outcomes and patient experience could all help to improve care for frail patients.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trialato / Fragilidad / Neoplasias de los Genitales Femeninos Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trialato / Fragilidad / Neoplasias de los Genitales Femeninos Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido